Saturday, March 23, 2019

Essay --

The United States of the States accounts for only 5% of the human beings population, yet as a nation, we devour over 50% of the worlds pharmaceutical medication and around 80% of the worlds ethical dose narcotics (American Addict). The increasing demand for prescription(prenominal) medication in America has evoked a national health crisis in which the government and double business benefit at the expense of the American normal.(II) The enacting of Medicare Part D in 2006 only helped to fuel Americas hunger for prescription medication. In 2003, President George W. Bush announced and signed the Medicare Prescription Drug, Improvement, and modernisation Act (also known as the Medicare modernisation Act, or MMA) on declination 8th. The roughly $400 billion dollar measure was marketed to the American public as something that will provide care for the millions of senior citizens who, at the time, were assay to afford prescription medication. This was the largest development of Med icare since 1965, which is when the program was initially created, and gave hope to those regard for positive aesculapian reform. According to title XI of the Medicare Prescription Drug, Improvement, and Modernization Act of 2003, the most significant change will be the affordability of prescription drugs by implementing the importation of drugs from Canada, along with necessary safety measures, in revise to lessen the cost (United States Congress, 832). For those who were in retirement homes and lacked a steady income, the affordability of drugs was a great deal a deciding factor in the decision to seek medical attention and the idea that those individuals ceased to live simply because they lacked the funds tugged at the heartstrings of some(prenominal) Americans. Although the Medicare Moderniza... ...pecially with the use of DTC advertising, to such a wide range of afflictions greatly change magnitude their consumer base, but unity of them proved to be deadly. In 1999, fou r years after Lilly sent study results to the U.S. Food and Drug Administration presentation Zyprexa didnt alleviate dementia symptoms in older patients, it began marketing the drug to those very people, according to documents unsealed in insurer suits against the company for overpayment.(Applbaum, 248). soon after it began to be used in those suffering from dementia, there were studies produces that showed an gain in death rate among elderly patients taking Zyprexa. In January of 2009, Eli Lilly and Company, who produced the drug, cease up settling the lawsuit and agreed to pay $1.415 billion which was one of the biggest corporate settlements in the history of pharmaceutical companies (Applbaum, 237).

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.